Attitude of German gynecologists towards prescribing HRT before and after the WHI study

Climacteric

Volumn 15, Issue 4, 2012, Pages 326-331

  Buhling, K J ^a   Von Studnitz, F S G ^a   Jantke, A ^b   Eulenburg, C ^a   Mueck, A O ^c  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

GYNECOLOGISTS; HORMONE REPLACEMENT THERAPY; SURVEY; WOMEN'S HEALTH INITIATIVE

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; ATTITUDE; DISEASE SEVERITY; FEMALE; GERMANY; GYNECOLOGIST; HORMONE SUBSTITUTION; HUMAN; INFORMED CONSENT; MAJOR CLINICAL STUDY; MALE; PHYSICIAN; PRESCRIPTION; PRIORITY JOURNAL; PRIVATE PRACTICE; RISK BENEFIT ANALYSIS; SYMPTOM; VASOMOTOR DISORDER;

ADULT; ATTITUDE OF HEALTH PERSONNEL; FEMALE; GERMANY; GYNECOLOGY; HORMONE REPLACEMENT THERAPY; HUMANS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; QUESTIONNAIRES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT;

EID: 84863582037     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.3109/13697137.2011.631061     Document Type: Article

References (22)

1. Rossouw JE, Anderson GL, Prentice RL, et al . Writing Group for the Women' s Health Initiative Investigators. Risks and benefi ts of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women' Health Initiative randomized controlled trial. JAMA 2002;288:321-33
2. Anderson GL, Limacher M, Assaf AR, et al . Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: The Women' Health Initiative randomized controlled trial. JAMA 2004;291:1701-12
3. Hormontherapie in der Peri- und Postmenopause (HT). Downloaded on http://www.awmf.org/uploads/tx-szleitlinien/015-062-S3-Hormontherapie-in-der- Peri-und-Postmenopause-HT-lang-09-2009-12-2011.pdf
4. Nassar AH, Abd Essamad HM, Awwad JT, e t al. Gynecologists' attitude towards hormone therapy in the post 'Women' s Health Inititative' study era. Maturitas 2005;52:18-25
5. Lazar Jr F, Costa-Paiva L, Morias SS, et al. The attitude of gynecologists in Sao Paulo, Brazil 3 years after the Women' s Health Initiative study. Maturitas 2007;56:129-41
6. Weissman-Brenner A, Brenner B, Sulkes J, Kaplan B. Women gynecologists' attitude toward their own health. Med Sci Monit 2010;16:PH35 - 9 Health Initiative: Cross sectional survey of users. BMJ 2003; 327:845-6
7. Haas JS, Kaplan CP, Gerstenberger EP, Kerlikowske K. Changes in the use of postmenopausal hormone therapy after the publication of clinical trial results. Ann Intern Med 2004;140: 184-188
8. Du Y, Doren M, Melchert HU, e t al. Differences in menopausal hormone therapy use among women in Germany between 1998 and 2003. BMC Women' s Health 2007;7:19
9. Du Y, Scheidt-Nave C, Schaffrath Rosario A, e t al. Changes of menopausal hormone therapy use pattern since 2000: Results of the Berlin Spandau Longitudinal Health Study. Climacteric 2009; 12:329-40
10. Strothmann A, Schneider HPG. Hormone therapy: The European women' s perspective. Climacteric 2003;5:337-46
11. Hoffmann M, Hammar M, Kjellgren KI, e t al. Changes in women' s attitudes towards and use of hormone replacement therapy after HERS and WHI. Maturitas 2005;52:11-17
12. Heier M, Moebus S, Meisinger C, e t al. Menopausal hormone therapy in Germany: Results of three national surveys from 1997 to 2003. Maturitas 2009;62:9-15
13. Canonico M, Oger E, Plu-Bureau G, e t al . Hormone therapy and venous thromboembolism among postmenopausal women. Impact of the route of estrogen administration and progestogens: THE ESTHER Study. Circulation 2007;115: 840-845
14. Canonico M, Fournier A, Carcaillon L, e t al . Postmenopausal hormone therapy and risk of idiopathic venous thromboembolism. Results from the E3N Cohort Study. Arterioscler Thromb Vasc Biol 2010;30:340-5
15. Renoux C, Dell-Aniello S, Suissa S. Hormone replacement therapy and the risk of venous thromboembolism: A populationbased study. J Thromb Haemost 2010;8:979-86
16. Renoux C, Dell'aniello S, Garbe D, Suissa S. Transdermal and oral hormone replacement therapy and the risk of stroke: A nested case-control study. BMJ 2010;340:c2519
17. Lokkegaard E, Andreasen AH, Jacobsen RK, e t al. Hormone therapy and risk of myocardial infarction: A national register study. Eur Hear J 2008;29:2660-8
18. Modena MG, Sismondi P, Mueck AO, et al. The TREAT Collaborative Group. New evidence regarding hormone replacement therapies is urgently required. Transdermal postmenopausal hormone therapy differs from oral hormone therapy in risks and benefi ts. Maturitas 2005;52:1-10
19. Canonico M, Plu-Bureau G, Lowe GDO, Scarabin P-Y. Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: A systematic review and meta-Analysis. BMJ 2008;336:1227-3
20. L'Hermite M, Simoncini T, Fuller S, Genazzani AR. Could transdermal estradiol - progesterone be a safer postmenopausal HRT' A review. Maturitas 2008;60:185-201
21. Speroff L. Transdermal hormone therapy and the risk of stroke and venous thrombosis. Climacteric 2010;13:429-32
22. Birkhaeuser MH, Panay N, Archer DF, e t al. Updated practical recommendations for hormone replacement therapy in the periand postmenopause. Climacteric 2008;11:108-23